Bioscience Reports · 2020 · 17 citations · 27 references
MedicineOncologyPharmacologyApoptosisGastrointestinal OncologyMolecular OncologyApoptosis In CancerApoptosis PharmacologyGastric CancerGastrointestinal PharmacologyCyclooxygenase InhibitorsCyclooxygenase-2 PathwayTumor Metastasis Biology
OBJECTIVE: The present study is designed to evaluate the anti-tumor effects of myrrh on human gastric cancer both in vitro and in vivo. METHODS: The gastric cancer cell proliferation was determined by MTT assay. Apoptosis was measured by flow cytometry and Hoechst 33342 staining. Wound healing was performed to evaluate the effects of myrrh on the migration. COX-2, PCNA, Bcl-2, and Bax expressions were detected by Western blot analysis. A xenograft nude mice model of human gastric cancer was established to evaluate the anti-cancer effect of myrrh in vivo. RESULTS: Myrrh significantly inhibited cellular proliferation, migration, and induced apoptosis in vitro as well as inhibited tumor growth in vivo. In addition, myrrh inhibited the expression of PCNA, COX-2, and Bcl-2 as well as increased Bax expression in gastric cancer cells. CONCLUSION: Myrrh may inhibit the proliferation and migration of gastric cancer cells, as well as induced their apoptosis by down-regulating the expression of COX-2.
27
Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Hitoshi Sawaoka, Shingo Tsuji, Masahiko Tsujii et al. · PubMed · 1999 · 272 citations
Medicine, Oncology, Pharmacology +12
Cyclooxygenase‐2 expression during carcinogenesis in the human stomach
Bastiaan P. van Rees, Kirsi Saukkonen, Ari Ristimäki et al. · The Journal of Pathology · 2001 · 156 citations · Full text
Medicine, Oncology, Pharmacology +15